Affordable Access

deepdyve-link
Publisher Website

Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis.

Authors
  • Hsueh, Yu-Wen1
  • Yeh, Tzu-Lin2, 3
  • Lin, Chien-Yu4, 5
  • Tsai, Szu-Ying6
  • Liu, Shu-Jung7
  • Lin, Chi-Min2
  • Chen, Hsin-Hao2, 8, 5
  • 1 Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan. , (Taiwan)
  • 2 Department of Family Medicine, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan. , (Taiwan)
  • 3 Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan. , (Taiwan)
  • 4 Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan. , (Taiwan)
  • 5 Department of Medicine, MacKay Medical College, New Taipei City, Taiwan. , (Taiwan)
  • 6 Department of Family Medicine, MacKay Memorial Hospital, Taipei, Taiwan. , (Taiwan)
  • 7 Department of Medical Library, MacKay Memorial Hospital, Tamsui Branch, New Taipei City, Taiwan. , (Taiwan)
  • 8 MacKay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan. , (Taiwan)
Type
Published Article
Journal
PeerJ
Publisher
PeerJ
Publication Date
Jan 01, 2020
Volume
8
Identifiers
DOI: 10.7717/peerj.8815
PMID: 32257643
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Metabolically healthy obesity (MHO) is defined as obesity with less than two parameters of metabolic abnormalities. Some studies report that MHO individuals show similar risk of cardiovascular disease (CVD) compared with metabolically healthy non-obese (MHNO) individuals, but the results are conflicting. Coronary artery calcium (CAC) reflects the extent of coronary atherosclerosis and is a useful tool to predict future risk of CVD. The objective of this meta-analysis was to investigate whether MHO is associated with elevated risk of CAC. We searched Cochrane, PubMed, and Embase up to April 19, 2019. Prospective cohort and cross-sectional studies examining the association between MHO subjects and CAC were included with MHNO as the reference. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random-effect models. Subgroup analysis and meta-regression were applied to define possible sources of heterogeneity. We conducted this research following a pre-established protocol registered on PROSPERO (CRD 42019135006). A total of nine studies were included in this review and six studies with 23,543 participants were eligible for the meta-analysis. Compared with MHNO subjects, MHO had a higher odds of CAC (OR 1.36, 95% CI [1.11 to 1.66]; I 2 = 39%). In the subgroup analysis, the risk associated with MHO participants was significant in cohort studies (OR = 1.47, 95% CI [1.15,1.87], I 2 = 0%), and borderline significant in cross-sectional studies. The risk of CAC was also significant in MHO participants defined by Adult Treatment Panel III (ATP III) (OR = 1.55, 95% CI [1.25,1.93], I 2 = 0%). The univariate meta-regression model showed that age and smoking status were possible effect modifiers for MHO and CAC risk. Our meta-analysis showed that MHO phenotypes were associated with elevated risk of CAC compared with MHNO, which reflects the extent of coronary atherosclerosis. People with obesity should strive to achieve normal weight even when only one metabolic abnormality is present. ©2020 Hsueh et al.

Report this publication

Statistics

Seen <100 times